Results | Across all devices, 1773 HR values were recorded. Twenty-seven data points were not obtained because of inability to complete the treadmill protocol or monitors losing skin contact. Heart rate ranged from 49 bpm to 200 bpm.
When compared with electrocardiogram, the HR monitors had variable accuracy as assessed by the concordance correlation coefficient (r c ) (Table) . While the Basis Peak overestimated HR during moderate exercise, with median differences of −8.9 and −7.3 bpm at 2 mph (P < .001) and 3 mph (P = .001), respectively, the Fitbit Charge HR underestimated HR during more vigorous exercise, with median differences of 7.2 and 6.4 bpm at 4 mph (P < .001) and 6 mph (P < .001), respectively (Wilcoxon signed-rank test comparing each device with electrocardiogram).
Bland-Altman analysis showed that variability occurred across the spectrum of midrange HRs during exercise, with less variability at the tail ends ( Figure) . The Apple Watch and Mio Fuse had 95% of differences fall within −27 bpm and +29 bpm of the electrocardiogram, while Fitbit Charge HR had 95% of values within −34 bpm and +39 bpm and the corresponding values for the Basis Peak were within −39 bpm and +33 bpm.
Body mass index, age, and sex did not influence monitor accuracy.
Discussion | We found variable accuracy among wrist-worn HR monitors; none achieved the accuracy of a chest strap-based monitor. In general, accuracy of wrist-worn monitors was best at rest and diminished with exercise.
This study is limited by examination of a convenience sample of 4 HR monitors in young, healthy adults exercising on a treadmill. Results should be confirmed with different types of exercise and with other devices. Continuous HR assessment, which is currently not feasible with all devices, would enable more detailed comparisons.
Electrode-containing chest monitors should be used when accurate HR measurement is imperative. While wristworn HR monitors are often used recreationally to track fitness, their accuracy varies; 2 of 4 monitors had suboptimal accuracy during moderate exercise. Because cardiac patients increasingly rely on these monitors to stay within physicianrecommended, safe HR thresholds during rehabilitation and exercise, appropriate validation of these devices in this group is imperative. To the Editor Almost 10 years since the Global Task Force introduced a classification of myocardial infarction by etiology, clinicians continue to debate the criteria and value of the diagnosis of type 2 myocardial infarction. Nagele 1 suggests the definition should be revised and that the diagnosis of myocardial infarction be restricted to patients in which myocardial ischemia and necrosis occur as a consequence of acute coronary artery occlusion. He suggests the term acute myocardial injury should be used in patients in which injury is due to other causes of myocardial oxygen supply-demand imbalance, irrespective of whether this is associated with myocardial ischemia. This term would encompass those patients currently classified as having type 2 myocardial infarction. While we agree that the universal definition of myocardial infarction requires refining to encourage a more consistent adoption in clinical practice-and have made similar recommendations in the past 2 -we believe the diagnosis of type 2 myocardial infarction should be retained.
Acute myocardial injury is a term that clinicians are likely to accept, and like acute kidney injury, it does not predicate the mechanism of injury. The likely mechanism of myocardial injury should guide the need for cardiac investigation and determine whether a diagnosis of myocardial infarction is appropriate. For example, while a patient with a submassive pulmonary embolism and an elevation in cardiac troponin levels may have both chest pain and evidence of myocardial ischemia on electrocardiography, a diagnosis of type 2 myocardial infarction is unhelpful, and coronary investigation or treatments are not indicated. However, a diagnosis of type 2 myocardial infarction may be helpful in patients with acute myocardial injury in which the presence of stable obstructive coronary artery disease has contributed, particularly when it has not been previously recognized and when outcomes may be improved through coronary revascularisation or medical therapy.
Observational studies consistently demonstrate that patients with acute myocardial injury are older and have more comorbidities [2] [3] [4] [5] and are therefore more likely to have coronary artery disease. These patients have poor outcomes and are more likely to be dead after 1 year than those with type 1 myocardial infarction. 2 In the absence of prospective and systematic studies of patients with acute myocardial injury, the proportion of patients with unrecognized coronary artery disease or imaging evidence of infarction in whom a diagnosis of type 2 myocardial infarction may be beneficial is unknown.
